Related Experiment Videos
Secretion of oxygen intermediates: role in effector functions of activated macrophages
Abstract:
The ability of macrophages to secrete reactive oxygen intermediates, such as superoxide or hydrogen peroxide, correlates closely with their capacity to kill trypanosoma, toxoplasma, leishmania, and candida. In this sense, secretion of oxygen intermediates is a biochemical marker of macrophage activation. The close correlation between oxidative metabolism and antimicrobial activity appears to stem from the direct involvement of oxygen intermediates in the killing of the same parasites by the macrophages. Similarly, there seem to be at least three experimental settings in which oxygen intermediates play a major role in nonphagocytic lysis of tumor cells by macrophages: in the presence of phorbol myristate acetate, of antitumor antibody, or of a peroxidase derived from eosinophils. These findings direct attention to antioxidant defenses in tumor cells and parasites. The oxidation-reduction cycle of glutathione is one major pathway used by tumor cells to limit oxidative injury by macrophages and granulocytes. Thus, cytotoxicity is augmented by inhibition of glutathione reductase or glutathione peroxidase, by interruption of glutathione synthesis, or by diversion of glutathione into another pathway. On the other hand, catalase appears to play a prominent role in limiting macrophage effector function against toxoplasma.
Insights
Macrophages use reactive oxygen intermediates to kill parasites and tumor cells. Inhibiting antioxidant defenses, like glutathione, enhances this cancer-killing ability, offering new therapeutic strategies.
Area of Science:
- Immunology
- Biochemistry
- Cell Biology
Background:
- Macrophages are crucial immune cells with antimicrobial and antitumor functions.
- Secretion of reactive oxygen intermediates (ROIs), such as superoxide and hydrogen peroxide, is a key marker of macrophage activation.
- ROIs are directly involved in killing parasites (Trypanosoma, Toxoplasma, Leishmania, Candida) and tumor cells.
Purpose of the Study:
- To explore the role of reactive oxygen intermediates in macrophage-mediated cytotoxicity.
- To investigate the antioxidant defense mechanisms employed by tumor cells and parasites against macrophage attack.
- To identify potential targets for enhancing macrophage-based therapies.
Main Methods:
- Correlating macrophage ROI secretion with antimicrobial and antitumor activity.
- Examining the role of ROIs in nonphagocytic lysis of tumor cells under specific experimental conditions (phorbol myristate acetate, antitumor antibody, eosinophil peroxidase).
- Investigating the impact of inhibiting or altering the glutathione antioxidant pathway on macrophage cytotoxicity.
Main Results:
- Macrophage secretion of ROIs strongly correlates with their ability to kill parasites and tumor cells.
- Oxygen intermediates are directly implicated in the cytotoxic mechanisms.
- Tumor cells utilize the glutathione oxidation-reduction cycle as a primary defense against macrophage-derived oxidative stress.
- Inhibiting glutathione synthesis or reductase/peroxidase activity potentiates macrophage cytotoxicity.
- Catalase plays a significant role in protecting Toxoplasma from macrophage effector functions.
Conclusions:
- Reactive oxygen intermediates are critical mediators of macrophage antimicrobial and antitumor activity.
- Targeting antioxidant pathways, particularly the glutathione system in tumor cells, can enhance macrophage-based cancer therapies.
- Understanding these interactions provides insights into host-pathogen and host-tumor dynamics.